Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.09 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |